D. N. Cohen

发表

The ambiguous boundary between EBV-related hemophagocytic lymphohistiocytosis and systemic EBV-driven T cell lymphoproliferative disorder.

Annette S. Kim, C. Vnencak-Jones, A. Yenamandra, 2014, International journal of clinical and experimental pathology.

Normal Respiratory Flora as a Cause of Community-Acquired Pneumonia

D. Musher, M. Rodriguez‐Barradas, B. Moss, 2020, Open forum infectious diseases.

Clinically significant hemolytic disease of the newborn secondary to passive transfer of anti‐D from maternal RhIG

P. Young, D. N. Cohen, Mary S Johnson, 2014, Transfusion.

A Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder Arising in a Patient With Multiple Myeloma and Cutaneous Amyloidosis.

M. Howard, C. Wieland, D. N. Cohen, 2016, The American Journal of dermatopathology.

BRAF inhibitor‐associated cutaneous squamous cell carcinoma: new mechanistic insight, emerging evidence for viral involvement and perspectives on clinical management

Julie H Wu, P. Rady, D. N. Cohen, 2017, The British journal of dermatology.

Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy

J. Sosman, Douglas B. Johnson, Y. Shyr, 2015, Clinical Cancer Research.

Title: Contribution of Beta-HPV Infection and UV-Damage to Rapid-onset Cutaneous Squamous Cell Carcinoma during BRAF-inhibition Therapy Running Title: Beta-HPV and UV-damage in cutaneous SCC during BRAF Therapy

J. Sosman, Douglas B. Johnson, Y. Shyr, 2015 .

Genomic landscape of a metastatic malignant proliferating tricholemmal tumor and its response to PI3K inhibition

Zhongming Zhao, C. Lovly, J. Gilbert, 2019, npj Precision Oncology.

TCF7L1 promotes skin tumorigenesis independently of β-catenin through induction of LCN2

Hoang Nguyen, Diane Yang, K. Tsai, 2017, eLife.

The contribution of human papilloma virus infection to cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia

S. Tyring, P. Rady, G. Rivero, 2021, EJHaem.

Indurated erythema of the neck and upper back

T. Rosen, Megan J Schlichte, J. C. Sheu, 2019, International journal of dermatology.

Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy

J. Sosman, Douglas B. Johnson, Erika K Wallender, 2013, Cancer Immunology Research.

A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis

M. Marcelli, D. N. Cohen, Kati Choi, 2019, Proceedings.

Spindle cell squamous carcinoma during BRAF inhibitor therapy for advanced melanoma: an aggressive secondary neoplasm of undetermined biologic potential.

J. Sosman, A. Boyd, D. N. Cohen, 2014, JAMA dermatology.

Local Tissue Response to Subcutaneous Administration of Ceftriaxone in an Animal Model

Katrina Chan, V. Tam, K. Garey, 2019, Antimicrobial Agents and Chemotherapy.

Stewart–Treves syndrome in a spinal cord injury patient with MYC amplification

I. Orengo, B. Krishnan, D. N. Cohen, 2017, JAAD case reports.